Intrinsic Value of S&P & Nasdaq Contact Us

Ichor Holdings, Ltd. ICHR NASDAQ

NASDAQ Global Select • Technology • Semiconductors • US • USD

SharesGrow Score
33/100
0/7 Pass
SharesGrow Intrinsic Value
$86.40
+35%
Analyst Price Target
$40.60
-36.6%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Ichor Holdings, Ltd. (ICHR) has a negative trailing P/E of -34.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 56.7 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -2.87%, forward earnings yield 1.77%. PEG 1.34.

Criteria proven by this page:

  • VALUE (34/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -34.8); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -2.87%); analyst consensus target implies downside from the current price ($40.60, 36.6%).
  • Forward P/E 56.7 — analysts expect a return to profitability with estimated EPS of $1.13 for FY2026.
  • PEG Ratio 1.34 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield -2.87% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 1.77% as earnings recover.
  • Analyst consensus target $40.60 (-36.6% downside) — analysts see meaningful downside risk at the current price level.

Overall SharesGrow Score: 33/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
33/100
SG Score
View full scorecard →
VALUE
34/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
58/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
20/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ICHR

Valuation Multiples
P/E (TTM)-34.8
Forward P/E56.7
PEG Ratio1.34
Forward PEG1.34
P/B Ratio2.77
P/S Ratio1.95
EV/EBITDA-243.8
Per Share Data
EPS (TTM)$-1.53
Forward EPS (Est.)$1.13
Book Value / Share$19.30
Revenue / Share$27.54
FCF / Share$-0.18
Yields & Fair Value
Earnings Yield-2.87%
Forward Earnings Yield1.77%
Dividend Yield0.00%
SharesGrow IV$86.40 (+35%)
Analyst Target$40.60 (-36.6%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 0.8 0.00 0.09 0.03 -
2017 12.0 -0.07 2.92 0.94 -
2018 7.0 0.49 2.03 0.49 -
2019 69.5 -0.87 3.37 1.20 -
2020 21.0 0.10 1.70 0.76 -
2021 18.3 0.25 2.60 1.19 -
2022 10.6 8.85 1.31 0.60 -
2023 -22.8 0.14 1.74 1.21 -
2024 -49.4 0.87 1.47 1.21 -
2025 -12.3 -0.09 0.98 0.68 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-3.11 $405.75M $16.66M 4.1%
2017 $1.96 $655.89M $51.39M 7.8%
2018 $2.30 $823.61M $57.88M 7%
2019 $0.47 $620.84M $10.73M 1.7%
2020 $1.42 $914.24M $33.28M 3.6%
2021 $2.45 $1.1B $70.9M 6.5%
2022 $2.51 $1.28B $72.8M 5.7%
2023 $-1.47 $811.12M $-42.99M -5.3%
2024 $-0.64 $849.04M $-20.82M -2.5%
2025 $-1.54 $947.65M $-52.78M -5.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.13 $1.00 – $1.22 $1.11B $1.09B – $1.12B 5
2027 $2.20 $1.93 – $2.53 $1.29B $1.17B – $1.38B 5
2028 $0.99 $0.90 – $1.06 $1.31B $1.22B – $1.38B 1
2029 $3.25 $2.94 – $3.48 $1.55B $1.44B – $1.63B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message